Morepen Laboratories Ltd.
MOREPENLAB Share PricePharmaceuticals & Drugs
₹43.45
0.8 (1.8%)
As on December 4, 2025
Exchange Scrips: BSE500288NSEMOREPENLABISININE083A01026
Market Cap ₹ 2,389 Cr
P/E Ratio 20.17
Dividend Yield 0.23 %
Performance
Market performance
Open42.7
High43.73
Volumes14,02,228
Prev43.45
Low42.37
As on2025-12-04
Historical performance
1 Year High91.7
3 Year High100.9
5 Year High100.9
1 Year Low42
3 Year Low24
5 Year Low23.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
2,389
Face Value (₹)
2
P/E Ratio
20.17
Dividend Yield
0.23 %
Investment Returns
1 Year
-49.7%
3 Years
40.6%
5 Years
30.9%
10 Years
40.2%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 43.23 | Bullish |
| 10-DMA | 43.43 | Bullish |
| 20-DMA | 44.82 | Bearish |
| 50-DMA | 47.16 | Bearish |
| 100-DMA | 50.5 | Bearish |
| 200-DMA | 53.73 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 35 | 35 | 35 | 35 | 35 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 35 | 35 | 35 | 35 | 35 |
| Public Investors | 461818 | 461145 | 468825 | 448326 | 430894 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 20.17.
- 3Y Stock Price CAGR of the stock is 11.0.
- The stock has a beta of 1.9.
- In the last financial year, the company had an EBITDA of ₹1924 Million.
- The company generated revenue of ₹18116 Million in the previous financial year.
Morepen Laboratories Ltd.
43.450.8 (1.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 503068.2
No. of Shares: 11578 (Approx)
Performance:-49.7%
P/L: ₹-496931.8
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
